Cooley advised Inscripta on the deal. Inscripta, a global leader in genome engineering technology, announced its acquisition of Infinome Biosciences and Sestina Bio. These acquisitions advance Inscripta’s…
Inscripta’s Acquisition of Infinome Biosciences and Sestina Bio
![](https://globallegalchronicle.com/wp-content/uploads/2023/01/michael_nelson.jpg)